HAL-MPE1 Safety and Tolerability Study
Public ClinicalTrials.gov record NCT02991885. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled, Multi-centre Study to Assess the Safety, Tolerability and Immunologic Effects of HAL-MPE1 Subcutaneous Immunotherapy in Adult and Paediatric Subjects With Peanut Allergy
Study identification
- NCT ID
- NCT02991885
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- HAL Allergy
- Industry
- Enrollment
- 42 participants
Conditions and interventions
Conditions
Interventions
- HAL-MPE1 Biological
- HAL-MPE1 placebo Drug
Biological · Drug
Eligibility (public fields only)
- Age range
- 5 Years to 50 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2016
- Primary completion
- Mar 31, 2019
- Completion
- Aug 31, 2019
- Last update posted
- Feb 18, 2020
2016 – 2019
United States locations
- U.S. sites
- 6
- U.S. states
- 6
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| John Hopkins Hospital University-Divison of Pediatric Allergy | Baltimore | Maryland | 21287 | — |
| Jaffe Food Allergy Institute, Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | — |
| UNC Rheumatolory Allergy & Immunology Clinic | Chapel Hill | North Carolina | 27517 | — |
| Allergy, Asthma and Immunology Center | Tulsa | Oklahoma | 74136 | — |
| South Texas Allergy & Asthma Medical Professionals (STAAMP) | San Antonio | Texas | 78251 | — |
| Asthma, Inc. | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02991885, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 18, 2020 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02991885 live on ClinicalTrials.gov.